{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:03:05Z","timestamp":1792544585595,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jaad.2021.01.059","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T02:46:11Z","timestamp":1611369971000},"page":"1092-1101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":218,"title":["Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations"],"prefix":"10.1016","volume":"86","author":[{"given":"Amit","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Alhusayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Daveluy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Gulliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarannum","family":"Jaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn S.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Kirchhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Lev-Tov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaad.2021.01.059_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","article-title":"Comparative overall comorbidity burden among patients with hidradenitis suppurativa","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2019.06.016","article-title":"All-cause mortality among patients with hidradenitis suppurativa: a population-based cohort study in the United States","volume":"81","author":"Reddy","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.01.059_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib4","first-page":"548","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"69","author":"Ebell","year":"2004","journal-title":"Am Fam Physician"},{"issue":"13","key":"10.1016\/j.jaad.2021.01.059_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archinternmed.2010.140","article-title":"A single-question screening test for drug use in primary care","volume":"170","author":"Smith","year":"2010","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jep.13046","article-title":"Feasibility of an 8-item questionnaire for early diagnosis of inflammatory bowel disease in primary care","volume":"25","author":"Chmiel","year":"2019","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.jaad.2021.01.059_bib7","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"535","key":"10.1016\/j.jaad.2021.01.059_bib8","first-page":"144","article-title":"Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies","volume":"57","author":"Mitchell","year":"2007","journal-title":"Br J Gen Pract"},{"issue":"10","key":"10.1016\/j.jaad.2021.01.059_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib10","article-title":"Patient health questionnaire depression scale as a suicide screening instrument in depressed primary care patients: a cross-sectional study","volume":"13","author":"Uebelacker","year":"2011","journal-title":"Prim Care Companion CNS Disord"},{"issue":"16","key":"10.1016\/j.jaad.2021.01.059_bib11","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.059_bib14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaad.2018.09.040","article-title":"Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa","volume":"80","author":"Wertenteil","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based clinical practice research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.01.059_bib16","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/jdv.15071","article-title":"Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study","volume":"32","author":"Lee","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis","volume":"8","author":"Kimball","year":"2018","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaad.2019.02.004","article-title":"Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"80","author":"Tannenbaum","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bjd.18093","article-title":"Associations of cutaneous and extracutaneous infections with hidradenitis suppurativa in U.S. children and adults","volume":"182","author":"Lee","year":"2020","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaad.2018.07.045","article-title":"Incidence of herpes zoster among patients with hidradenitis suppurativa: a retrospective population-based cohort analysis","volume":"79","author":"Wertenteil","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.059_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000490002","article-title":"Inflammation: a contributor to depressive comorbidity in inflammatory skin disease","volume":"31","author":"Farzanfar","year":"2018","journal-title":"Skin Pharmacol Physiol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) Project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib23","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjd.16998","article-title":"Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study","volume":"180","author":"Theut Riis","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jid.2017.06.020","article-title":"Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish Nationwide Registry study","volume":"138","author":"Huilaja","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2021.01.059_bib27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","article-title":"Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis","volume":"155","author":"Machado","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.01.059_bib29","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1016\/j.jid.2018.06.171","article-title":"Women with hidradenitis suppurativa have an elevated risk of suicide","volume":"138","author":"Tiri","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa","volume":"198","author":"K\u00f6nig","year":"1999","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1590\/S0365-05962012000600024","article-title":"Risk factors for hidradenitis suppurativa: a pilot study","volume":"87","author":"Schmitt","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.01.059_bib33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00403-018-1867-z","article-title":"Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study","volume":"310","author":"Akdogan","year":"2018","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjd.15939","article-title":"Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.01.059_bib38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/jamadermatol.2019.2610","article-title":"Incidence of long-term opioid use among opioid-naive patients with hidradenitis suppurativa in the United States","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib39","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jid.2018.01.009","article-title":"Hidradenitis suppurativa is associated with polycystic ovary syndrome: a population-based analysis in the United States","volume":"138","author":"Garg","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib40","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1111\/ced.13922","article-title":"Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis","volume":"44","author":"Phan","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"7121","key":"10.1016\/j.jaad.2021.01.059_bib41","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib42","doi-asserted-by":"crossref","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.059_bib43","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaad.2018.01.014","article-title":"Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.01.059_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41584-019-0279-6","article-title":"Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets","volume":"15","author":"Aletaha","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.01.059_bib46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib47","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2017.08.042","article-title":"Hidradenitis suppurativa and diabetes mellitus: a systematic review and meta-analysis","volume":"78","author":"Bui","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.01.059_bib49","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/ijd.14210","article-title":"The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in Northern Peninsular Malaysia: a multicenter study","volume":"57","author":"Loo","year":"2018","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ad.2018.10.020","article-title":"Association between hidradenitis suppurativa and metabolic syndrome: a systematic review and meta-analysis","volume":"110","author":"Rodr\u00edguez-Zu\u00f1iga","year":"2019","journal-title":"Actas Dermosifiliogr"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","article-title":"Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data","volume":"18","author":"Kwa","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.01.059_bib52","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib53","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"Xu","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.059_bib54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaad.2016.03.025","article-title":"Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS)","volume":"75","author":"Gonz\u00e1lez-L\u00f3pez","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.01.059_bib56","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jdv.14076","article-title":"Assessment of subclinical atherosclerosis in hidradenitis suppurativa","volume":"31","author":"Pascual","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib57","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/bjd.15778","article-title":"Hidradenitis suppurativa and electrocardiographic changes: a cross-sectional population study","volume":"178","author":"Juhl","year":"2018","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.01.059_bib58","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","article-title":"Overall and subgroup prevalence of Crohn disease among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"154","author":"Garg","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.059_bib59","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.01.059_bib60","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jid.2016.04.003","article-title":"Hidradenitis suppurativa and Inflammatory bowel disease: a cross-sectional study of 3,207 patients","volume":"136","author":"Shalom","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.01.059_bib61","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1111\/jdv.14097","article-title":"Hidradenitis suppurativa association at the time of, or subsequent to, diagnosis of inflammatory bowel disease in a large US patient population","volume":"31","author":"Cices","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.059_bib62","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jbspin.2017.09.005","article-title":"Association between hidradenitis suppurativa and spondyloarthritis","volume":"85","author":"Fauconier","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijwd.2017.10.007","article-title":"Quality of life and sexual health in patients with hidradenitis suppurativa","volume":"4","author":"Alavi","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000481117","article-title":"Health-related quality of life of patients with hidradenitis suppurativa measured with the 15D instrument and comparison with the general population and patients with psoriasis","volume":"4","author":"Kluger","year":"2018","journal-title":"Skin Append Disord"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.059_bib66","first-page":"502","article-title":"Incidence of sexual dysfunction among patients with hidradenitis suppurativa: a population-based retrospective analysis","volume":"179","author":"Slyper","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib67","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.15770","article-title":"Prevalence of hidradenitis suppurativa among patients with down syndrome: a population-based cross-sectional analysis","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.059_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5826\/dpc.0903a03","article-title":"Disseminate recurrent folliculitis and hidradenitis suppurativa are associated conditions: results from a retrospective study of 131 patients with Down syndrome and a cohort of 12,351 pediatric controls","volume":"9","author":"Sechi","year":"2019","journal-title":"Dermatol Pract Concept"},{"issue":"11","key":"10.1016\/j.jaad.2021.01.059_bib69","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/jdv.15764","article-title":"High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors","volume":"33","author":"Dur\u00e1n-Vian","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.059_bib70","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/bjd.16931","article-title":"Incidence of obstructive sleep apnoea in patients with hidradenitis suppurativa: a retrospective population-based cohort analysis","volume":"179","author":"Wertenteil","year":"2018","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.01.059_bib71","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/ced.13606","article-title":"Thyroid function in\u00a0hidradenitis suppurativa: a population-based cross-sectional study from Denmark","volume":"43","author":"Miller","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2340\/00015555-2072","article-title":"A population-and hospital-based cross-sectional study of renal function in hidradenitis suppurativa","volume":"96","author":"Miller","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaad.2017.02.055","article-title":"Risk of Alzheimer's disease is not increased among patients with hidradenitis suppurativa: a retrospective population-based cohort analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.059_bib74","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjd.15064","article-title":"Patients with hidradenitis suppurativa have no increased risk of Alzheimer disease","volume":"177","author":"Theut Riis","year":"2017","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.059_bib75","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamadermatol.2018.5230","article-title":"Association between hidradenitis suppurativa and lymphoma","volume":"155","author":"Tannenbaum","year":"2019","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221002139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221002139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:01:22Z","timestamp":1759273282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221002139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0190962221002139"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.01.059","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}